An drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according to new research.The treatment, lecanemab, was found to triple the risk of death within a year, compared with dementia sufferers not prescribed the drug.Previous studies have suggested it slowed the progression of the incurable brain disease by 25 per cent, providing patients with an estimated four to six months more of healthy life.
Load More
Load More